Skip to main content

Table 1 Epidemiological and clinical characteristics and outcomes of community-acquired urinary tract infection in older patients according to multidrug-resistant or non-multidrug-resistant bacteria

From: Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection

 

Total cases

n 348

MDR bacteria

n 144

Non-MDR bacteria

n 204

p

Male sex, n (%)

179 (51.4)

82 (56.9)

97 (47.5)

0.102

Age (years), median [IQR]

81 [75–87]

80 [75–88]

81 [75–87]

0.719

Age ≥ 75 years, n (%)

274 (78.7)

111 (77.1)

163 (79.9)

0.595

McCabe ≥ 2, n (%)

268 (77)

113 (78.5)

155 (75.9)

0.607

Comorbidites

 Dementia, n (%)

104 (29.9)

52 (36.1)

52 (25.5)

0.043

 Diabetes mellitus, n (%)

130 (37.4)

56 (38.9)

74 (36.3)

0.653

 COPD, n (%)

51 (14.7)

20 (13.9)

31 (15.2)

0.761

 CKD, n (%)

113 (32.5)

44 (30.6)

69 (33.8)

0.562

 Cancer, n (%)

77 (22.1)

30 (20.8)

47 (23)

0.695

 Indwelling urinary catheter, n (%)

81 (23.3)

40 (27.8)

41 (20.1)

0.122

 HCA-UTI, n (%)

214 (61.5)

110 (76.4)

104 (50.9)

 < 0.001

 Previous hospitalization, n (%)

128 (36.8)

67 (46.5)

61 (29.9)

0.002

 Previous antimicrobial therapy, n (%)

182 (52.3)

94 (65.3)

88 (43.1)

 < 0.001

 Nursing home residence, n (%)

28 (8)

20 (13.9)

8 (3.9)

0.001

Clinical characteristics

 APACHE II, median [IQR]

12 [9–17]

13 [9–17]

12 [9–17]

0.981

 Fever, n (%)

239 (68.7)

98 (68.1)

141 (69.1)

0.907

 RR ≥ 22, n (%)

71 (20.4)

23 (15.9)

48 (23.5)

0.105

 Altered mental status, n (%)

158 (45.4)

76 (52.8)

82 (40.2)

0.021

 SBP < 100, n (%)

62 (17.8)

30 (20.8)

32 (15.7)

0.255

 qSOFA ≥ 2, n (%)

90 (25.9)

40 (27.8)

50 (24.5)

0.535

 Sepsis (SOFA ≥ 2), n (%)

184 (52.9)

78 (54.1)

106 (51.9)

0.744

 Septic shock-3, n (%)

56 (16)

25 (17.4)

31 (15.2)

0.657

 Albumin, median [IQR]

3.1 [2.8–3.5]

3.0 [2.7–3.5]

3.2 [2.9–3.5]

0.063

 Leukocytosis, median [IQR]

13,200 [9400–18575]

12,800 [9025–18425]

13,500 [9750–18600]

0.170

 Polymicrobial UTI, n (%)

36 (10.3)

21 (14.6)

15 (7.4)

0.033

 Bacteremia, positive/total blood cultures (%)

84/209 (40.2)

35/85 (41.2)

49/124 (39.5)

0.951

 IEAT, n (%)

81 (23.3)

48 (33.3)

33 (16.2)

 < 0.001

Outcomes

 In-hospital mortality, n (%)

30 (8.6)

11 (7.6)

19 (9.3)

0.699

 30-day mortality, n (%)

44 (12.6)

20 (13.9)

24 (11.8)

0.624

 Length of hospital stay (days), median [IQR]

5 [4–8]

6 [4–8]

5 [4–7]

0.029

  1. MDR, multidrug-resistant; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; HCA-UTI, healthcare associated-UTI; RR, respiratory rate; SBP, systolic blood pressure; IEAT, inadequate empiric antimicrobial therapy